Lipase activities were measured at pH 4 and pH 8 in the placentas of rats made diabetic by
streptozotocin treatment and also in the placentas of women classified as having 1) impaired …

Objective Maternal obesity increases the incidence of excess adiposity in newborns,
resulting in lifelong diabetes risk. Elevated intrauterine fetal adiposity has been attributed to …

Abstract Knowledge of the consequences of maternal obesity in human placental fatty acids
(FA) transport and metabolism is limited. Animal studies suggest that placental uptake of …

Obesity in pregnancy is associated with increased fetal growth and adiposity, which, in part,
is determined by transplacental nutrient supply. Trophoblast uptake and intracellular …

Maternal lipids are strong determinants of fetal fat mass. Here we review the overall lipid
metabolism in normal and gestational diabetes mellitus (GDM) pregnancies. During early …

The distribution of fatty acids was determined by gas-liquid chromatography in total lipid and
triglyceride fraction of extracts of several tissues of streptozotocin-diabetic rats and their …

There is increasing recognition that maternal glucose concentrations lower than those
previously used for diagnosis of gestational diabetes mellitus (GDM) and targeted for …

Diabet. Med. 28, 1053–1059 (2011) Abstract Aims To evaluate the potential contribution of
maternal glucose and lipids to fetal metabolic variables and growth in pregnancies with …

Pregestational obesity is a significant risk factor for adverse pregnancy outcomes. Maternal
obesity is associated with a specific proinflammatory, endocrine and metabolic phenotype …

The fetal demand for FFA increases as gestation proceeds, and LPL represents one
potential mechanism for increasing placental lipid transport. We examined LPL activity and …